Wall Street Reporting  on Pressure BioSciences Latest News

Opportunity Stocks Buying PBIO OTCQB - Watch Video

Target Price Now  Raised To $1.00 On News STRONG BUY

StockNewsNow.com Publishes Business and Earnings Review Q1 2016 with Pressure BioSciences, Inc.  - Daily Trader

LOS ANGELES, June. 2, 2016 /PRNewswire/ -- StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Newscast – Business and Earnings Review with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO), a life sciences company that develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market, according to the Company's website (see here: www.PressureBioSciences.com). The video interview was recorded on Friday, May 20th, 2016 via Skype from SNN's office in Los Angeles, CA and Pressure BioSciences' headquarters in Boston, MA.

Click the following link to watch the SNNLive Video Interview on StockNewsNow.com:

SNNLive Newscast with Pressure BioSciences, Inc. – Highlights of Q1 2016 Financials and Near-Term Goals for Q2-Q4 2016

Please review important disclosures on our website at: http://stocknewsnow.com/legal.php#disclaimer

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and forensic applications.    

For more information, visit: www.PressureBioSciences.com

 


PBIO-OTCQX: These shares have doubled from their $0.26 cent Nov 2015 low   . Wall Street Reporting  looks for a retest of the $0.55 cent recent peak with a longer term Target Price now raised of $1.00  .

Several analaysts have placed a $2.00 target price on these shares



 

 

 

 

 

 


Recent Small Cap News

Top Income Funds For 2016
High Income High Risk 11.8%  Dividend
Stock Alert YPPN Doubles On Restructure
Mining Stock Reporter Highlights Picks 2016
Top Biotech Funds For Your Portfolio
Daily Trader